EU drug regulator says more data needed on impact of Omicron on vaccines

FILE PHOTO: The exterior of EMA, European Medicines Agency is seen in Amsterdam, Netherlands December 18, 2020. REUTERS/Piroschka van de Wouw

(Reuters) – The European Union’s drug regulator said on Tuesday more data was needed to understand the impact of the highly contagious Omicron coronavirus variant on currently approved COVID-19 vaccines, and expressed doubt on the need for a fourth booster dose.

Repeated vaccinations within short intervals would not a represent a sustainable long-term strategy, the European Medicines Agency’s Head of Vaccines Strategy, Marco Cavaleri, told a media briefing.

Source: Read Full Article